
    
      The DIAMOND-AF II Study is a prospective, non-randomized (single-group assignment) trial
      being performed at multiple centers in the United States, Canada and Europe to evaluate the
      safety and effectiveness of the DiamondTemp Ablation System for the treatment of patients
      with persistent atrial fibrillation.
    
  